Sort
146,196 grants matching “diabetes”
Phenotyping Genetic Disorders of Hepatic Lipid and Lipoprotein Metabolism in Cells, Mice, and Men
$953,882Henry N Ginsberg · Columbia University Health Sciences · R35 · FY2018 · HL
Phenotyping Genetic Disorders of Hepatic Lipid and Lipoprotein Metabolism in Cells, Mice, and Men
$953,882Henry N Ginsberg · Columbia University Health Sciences · R35 · FY2019 · HL
Phenotyping Genetic Disorders of Hepatic Lipid and Lipoprotein Metabolism in Cells, Mice, and Men
$953,882Henry N Ginsberg · Columbia University Health Sciences · R35 · FY2021 · HL
Phenotyping Genetic Disorders of Hepatic Lipid and Lipoprotein Metabolism in Cells, Mice, and Men
$953,882Henry N Ginsberg · Columbia University Health Sciences · R35 · FY2022 · HL
Maryland Polycystic Kidney Disease Research Core Center (MPKD-RCC)
$953,773Terry J Watnick · University Of Maryland Baltimore · U54 · FY2025 · DK
Epigenetic control during embryogenesis
$953,313Kathrin Muegge · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Delivery of peptides for inducing voiding associated with neurological retention
$953,265Lesley Marson · Dignify Therapeutics, Llc · R42 · FY2016 · NS
Development and Performance Evaluation of a Handheld Noninvasive Glucose Monitor
$953,153Rebecca A Burrell · Grove Instruments, Inc. · R44 · FY2008 · DK
Sphingosine Kinase Inhibitors as Anti-Retinopathy Agents
$953,134Lynn W Maines · Apogee Biotechnology Corporation · R44 · FY2007 · EY
A Novel Immunological-Directed Biotherapy for Treating Rheumatoid Arthritis
$952,967Gary Fanger · Rise Therapeutics, Llc · R44 · FY2025 · AG
Immunohistochemistry Core Laboratory
$952,585Mark Raffeld · Division Of Basic Sciences - Nci · ZIC · FY2015 · CA
(CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air Pollution
$952,577Sanjay Rajagopalan · Case Western Reserve University · R35 · FY2024 · ES
Aging-related Traits and Disease Risk Factors in a Sardinian Population Cohort
$952,184David Schlessinger · National Institute On Aging · ZIA · FY2017 · AG
PLT+ Characterization and IND-Enabling Studies
$952,100Bradford Dykstra · Stellular Bio, Inc. · R44 · FY2021 · HL
Increasing Sleep Duration: A Novel Approach to Weight Control
$952,080Rena R Wing · Miriam Hospital · U01 · FY2010 · CA
Tools and Practices to Decrease CVD and Complications in the Diabetic Population of Mexico
$951,983Cecilia Ballesteros Rosales · University Of Arizona · R01 · FY2019 · HL
GENERAL CLINICAL RESEARCH CENTER
$951,937Medical University Of South Carolina · M01 · FY2000 · RR
Common Genetic Variation and Quantitative Diabetes Traits
$951,872James B Meigs · Massachusetts General Hospital · R01 · FY2011 · DK
Clinical Center for Look AHEAD: Action for Health in Diabetes
$951,773Anne L Peters · University Of Southern California · U01 · FY2010 · DK
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
$951,710Megan Sykes · Columbia University Health Sciences · U01 · FY2022 · DK
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
$951,710Megan Sykes · Columbia University Health Sciences · U01 · FY2021 · DK
Co-creating and implementing contextually responsive physical activity interventions with low-income adolescents
$951,652Deanna Marie Hoelscher · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · MD
Oral Health Advocates in Public Housing
$951,573Michelle M Henshaw · Boston University Medical Campus · U54 · FY2009 · DE
Impact of obesity on SARS-CoV-2 infection and reciprocal effects of SARS-CoV-2 on metabolic disease
$951,400Charles T Roberts · Oregon Health & Science University · R01 · FY2024 · DK
Modeling autoimmune pathogenesis and beta cell destruction by T1D immune systems
$951,344Megan Sykes · Columbia University Health Sciences · U01 · FY2020 · DK